Question 1

What specific benefits do you think the AWARE approach could bring to my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the AWARE writing task fit into the overall therapy sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or downsides of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any negative effects from the AWARE intervention?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available if I do not qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication clinical trial (NCT06088303). Contact the study team or your healthcare provider for specific answers.

What this study is about